SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced select unaudited preliminary ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

The Company expects to provide further information regarding its full year 2026 financial guidance on its fourth quarter earnings call in February.

Affirms guidance of Adjusted EBITDA positivity in Q4 2025.

Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue ...

The Department of Justice (DOJ) has launched a probe into the Federal Reserve’s renovation of its headquarters, a move that ...

Estimated Q4 2025 Revenue of $28.8 million, an increase of 41%; Grew full-year revenue to an estimated $88.5 million, an increase of 24%; Affirms guidance of Adjusted EBITDA positivity in Q4 2025.

(NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a conference call the ...

Eskom has entered 2026 with a significant increase in power generation capacity, reflecting improvements in operational ...

Kyle Busch's lawsuit against Pacific Life and his former insurance agent provides a window into potential issues around ...

Year-over-year inbound cargo volumes are still expected to decline through April, according to the Global Port Tracker.